[HTML][HTML] Can phosphodiesterase 4 inhibitor therapy be used in respiratory diseases other than chronic obstructive pulmonary disease?
MR Goonathilake, S Waqar, S George… - Cureus, 2022 - ncbi.nlm.nih.gov
Abstract Selective phosphodiesterase 4 (PDE4) inhibitors have been extensively studied for
the treatment of various respiratory diseases due to their broad anti-inflammatory and/or …
the treatment of various respiratory diseases due to their broad anti-inflammatory and/or …
Molecular insights into the interaction of eighteen different variants of SARS-CoV-2 spike proteins with sixteen therapeutically important phytocompounds: in silico …
B Batra, S Srinivasan, SG Gopalakrishnan… - Journal of …, 2023 - Taylor & Francis
SARS-CoV-2 has mutated many times among different populations. We analyzed wild-type
spike protein and 18 different variants of SARS-CoV-2 spike protein known until the …
spike protein and 18 different variants of SARS-CoV-2 spike protein known until the …